BIAMULINE
TIAMULINE HYDROGENOFUMARATE
About this veterinary medicine
BIAMULINE is a veterinary medicine in the form of solution buvable containing tiamuline hydrogenofumarate. It is marketed by BIOVE. It holds a marketing authorisation in Tunisia under number 139.1362.17.
Characteristics
- Form
- Solution Buvable
- Presentation
- Flacon de 1 litre
- Route of administration
- Oral route
- Laboratory
- BIOVE
- Country
- France
Regulatory status — Tunisie
🟢 Marketing authorisation in force
Authorisation no. : 139.1362.17 — Authorisation date : 29/05/2017
⚠️ Regulatory alerts
No alert reported.
🔴 Batch recalls
No batch currently reported as recalled.
📦 Availability in Tunisia
Reported by TunisieVet veterinarians.
No availability information yet.
🔒 Availability reporting is reserved for signed-in veterinarians.
Sources
- dpm verified on 30/09/2026
Last synchronisation : 30/09/2026
Report availability
Sign in to your veterinarian account to report availability.
Log InOnly veterinarians can report availability.
TunisieVet in your pocket 📱🐾 Access your veterinary services wherever you are. [ Download the app ]
Learn more